BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kardani K, Basimi P, Fekri M, Bolhassani A. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development. Expert Rev Clin Pharmacol 2020;13:1001-46. [PMID: 32838584 DOI: 10.1080/17512433.2020.1814743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Curry K, Chandler R, Kostas-Polston EA, Alexander I, Orsega S, Johnson-Mallard V. Recommendations for managing sexually transmitted infections: Incorporating the 2021 guidelines. Nurse Pract 2022;47:10-8. [PMID: 35349512 DOI: 10.1097/01.NPR.0000822528.27483.b2] [Reference Citation Analysis]
2 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
3 Kardani K, Bolhassani A, Kardani M, Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. JoMMID 2021;9:122-32. [DOI: 10.52547/jommid.9.3.122] [Reference Citation Analysis]
4 Kardani K, Sadat SM, Kardani M, Bolhassani A. The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Rev Vaccines 2021;20:839-55. [PMID: 34114513 DOI: 10.1080/14760584.2021.1941895] [Reference Citation Analysis]
5 Kardani K, Bolhassani A. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches. PLoS One 2021;16:e0247396. [PMID: 33606823 DOI: 10.1371/journal.pone.0247396] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Basak S, Packirisamy G. Nano-based antiviral coatings to combat viral infections. Nano-Structures & Nano-Objects 2020;24:100620. [DOI: 10.1016/j.nanoso.2020.100620] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]